trial · primary record
186RNL
Leptomeningeal Metastasis
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 37 |
| Primary completion | 2026-10-19 |
| Primary endpoint | Incidence and severity of adverse events (AE) and serious adverse events (SAE) |
| Registry ID | NCT05034497 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:36.306Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05034497
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.